HealthEquity (HQY) Stock Overview
Provides technology-enabled services platforms to consumers and employers in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HQY from our risk checks.
HQY Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
HealthEquity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$77.96 |
| 52 Week High | US$116.65 |
| 52 Week Low | US$72.76 |
| Beta | 0.26 |
| 1 Month Change | -0.78% |
| 3 Month Change | -17.20% |
| 1 Year Change | -5.16% |
| 3 Year Change | 36.58% |
| 5 Year Change | 9.82% |
| Change since IPO | 342.95% |
Recent News & Updates
Recent updates
The Market's Not Diagnosing HealthEquity Accurately
Jan 14Here's Why We Think HealthEquity (NASDAQ:HQY) Might Deserve Your Attention Today
Jan 01
These 4 Measures Indicate That HealthEquity (NASDAQ:HQY) Is Using Debt Reasonably Well
Aug 06Returns At HealthEquity (NASDAQ:HQY) Are On The Way Up
Jul 10Here's Why We Think HealthEquity (NASDAQ:HQY) Is Well Worth Watching
Jun 25HealthEquity, Inc.'s (NASDAQ:HQY) Share Price Matching Investor Opinion
May 19HealthEquity: Robust Growth, But No Margin Of Safety
Mar 17HealthEquity: High Marks For Recent Profit Growth
Nov 20
Expanding HSA Market Dominance Fuels Revenue And Innovates Healthcare Financial Services
HealthEquity's expansion in the HSA market and strategic acquisitions, including BenefitWallet, aim to grow its customer base and custodial revenue.HealthEquity: Compelling Catalysts, Fairly Valued, Reiterate Buy
Aug 27HealthEquity: A Trading Vehicle Performing As Expected, Strong Growth Hard To Ignore
Jun 04HealthEquity: Strong Growth And Healthy Cash Flows Changed My Mind
May 29HealthEquity: Multiple Compression Has Finally Made It A Buy
Mar 21Shareholder Returns
| HQY | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -7.9% | 4.8% | 3.3% |
| 1Y | -5.2% | -26.9% | 28.1% |
Return vs Industry: HQY exceeded the US Healthcare industry which returned -25.4% over the past year.
Return vs Market: HQY underperformed the US Market which returned 29.7% over the past year.
Price Volatility
| HQY volatility | |
|---|---|
| HQY Average Weekly Movement | 5.6% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: HQY has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HQY's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 2,814 | Scott Cutler | www.healthequity.com |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs.
HealthEquity, Inc. Fundamentals Summary
| HQY fundamental statistics | |
|---|---|
| Market cap | US$7.11b |
| Earnings (TTM) | US$215.20m |
| Revenue (TTM) | US$1.31b |
Is HQY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HQY income statement (TTM) | |
|---|---|
| Revenue | US$1.31b |
| Cost of Revenue | US$400.31m |
| Gross Profit | US$913.12m |
| Other Expenses | US$697.92m |
| Earnings | US$215.20m |
Last Reported Earnings
Jan 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.55 |
| Gross Margin | 69.52% |
| Net Profit Margin | 16.38% |
| Debt/Equity Ratio | 45.4% |
How did HQY perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 05:47 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2026/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HealthEquity, Inc. is covered by 22 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mark Marcon | Baird |
| Peter Warendorf | Barclays |
| Alexander Paris | Barrington Research Associates, Inc. |